Search research articles
Contact Us
Filters
Showing results (771-780 of 819) with videos related to
Page
of 82
Sort By:
Clinical Genetics
|
April 11, 2008
CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine
A H Stam, K R J Vanmolkot, H P H Kremer, et al.
The Science of the Total Environment
|
July 23, 2013
Biomarkers of occupational exposure to air pollution, inflammation and oxidative damage in taxi drivers
Natália Brucker, Angela M Moro, Mariele F Charão, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Cephalalgia : an International Journal of Headache
|
July 10, 2026
Endocannabinoid cerebrospinal fluid levels in migraine and its relation to symptoms of depression
Aster V E Harder, Xinyu Di, Wendy M Winter, et al.
Cephalalgia : an International Journal of Headache
|
May 31, 2013
Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial
Leopoldine A Wilbrink, Onno P M Teernstra, Joost Haan, et al.
Pain
|
May 16, 2013
Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice
Mona Lisa Chanda, Alexander H Tuttle, Inna Baran, et al.
Archives of Neurology
|
January 14, 2009
Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake
Boukje de Vries, Hafsa Mamsa, Anine H Stam, et al.
Cephalalgia : an International Journal of Headache
|
April 10, 2016
Cerebellar function and ischemic brain lesions in migraine patients from the general population
Hille Koppen, Henk-Jan Boele, Inge H Palm-Meinders, et al.
The Lancet. Neurology
|
June 19, 2021
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial
Leopoldine A Wilbrink, Ilse F de Coo, Patty G G Doesborg, et al.
Frontiers in Immunology
|
October 31, 2022
IL-6 deletion decreased REV-ERBα protein and influenced autophagy and mitochondrial markers in the skeletal muscle after acute exercise
Ana P Pinto, Vitor R Muñoz, Alisson L da Rocha, et al.
Page
of 82
Search research articles
Search
Showing results (771-780 of 819) with videos related to
Sort By:
Page
of 82
Clinical Genetics
|
April 11, 2008
CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine
A H Stam, K R J Vanmolkot, H P H Kremer, et al.
The Science of the Total Environment
|
July 23, 2013
Biomarkers of occupational exposure to air pollution, inflammation and oxidative damage in taxi drivers
Natália Brucker, Angela M Moro, Mariele F Charão, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial
S Lonardi, A Sobrero, G Rosati, et al.
Cephalalgia : an International Journal of Headache
|
July 10, 2026
Endocannabinoid cerebrospinal fluid levels in migraine and its relation to symptoms of depression
Aster V E Harder, Xinyu Di, Wendy M Winter, et al.
Cephalalgia : an International Journal of Headache
|
May 31, 2013
Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial
Leopoldine A Wilbrink, Onno P M Teernstra, Joost Haan, et al.
Pain
|
May 16, 2013
Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice
Mona Lisa Chanda, Alexander H Tuttle, Inna Baran, et al.
Archives of Neurology
|
January 14, 2009
Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake
Boukje de Vries, Hafsa Mamsa, Anine H Stam, et al.
Cephalalgia : an International Journal of Headache
|
April 10, 2016
Cerebellar function and ischemic brain lesions in migraine patients from the general population
Hille Koppen, Henk-Jan Boele, Inge H Palm-Meinders, et al.
The Lancet. Neurology
|
June 19, 2021
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial
Leopoldine A Wilbrink, Ilse F de Coo, Patty G G Doesborg, et al.
Frontiers in Immunology
|
October 31, 2022
IL-6 deletion decreased REV-ERBα protein and influenced autophagy and mitochondrial markers in the skeletal muscle after acute exercise
Ana P Pinto, Vitor R Muñoz, Alisson L da Rocha, et al.
Page
of 82